Mark Puder, MD, PhD
Boston Children's Hospital
3
3
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Kalev Teder, M.D.
Department of Surgery, Central Hospital, Norrkoping, Sweden.
Shared therapeutic areas:
Kenneth Setchell, PhD
Children's Hospital Medical Center, Cincinnati
Shared therapeutic areas:
Tomasz Masior
VectivBio AG
Shared therapeutic areas:
John Magee, MD
University of Michigan Medical Center, Ann Arbor
Shared therapeutic areas:
Ervin Toth, M.D.
Department of Endoscopy, University Hospital MAS, Malmö, Sweden.
Shared therapeutic areas:
Ryan Hurt, MD, PhD
Mayo Clinic
Shared therapeutic areas:
Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Eric P Kullman, M.D.
Department of Surgery, University Hostpital, Linkoping, Sweden.
Shared therapeutic areas:
Christine Henriksen, PhD
University of Oslo
Shared therapeutic areas:
Li Yang, MD
West China Hospital,Chengdu, Sichuan, China
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients
Cholestasis Prevention: Efficacy of IV Fish Oil
All 3 trials loaded